Application Nr Approved Date Route Status External Links
BLA103950 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Kineret Is An Interleukin-1 Receptor Antagonist Indicated For: Rheumatoid Arthritis (Ra) Reduction In Signs And Symptoms And Slowing The Progression Of Structural Damage In Moderately To Severely Active Rheumatoid Arthritis, In Patients 18 Years Of Age Or Older Who Have Failed 1 Or More Disease Modifying Antirheumatic Drugs (Dmards) ( 1.1 ) Cryopyrin-Associated Periodic Syndromes (Caps) Treatment Of Neonatal-Onset Multisystem Inflammatory Disease (Nomid) ( 1.2 ) 1.1 Active Rheumatoid Arthritis Kineret Is Indicated For The Reduction In Signs And Symptoms And Slowing The Progression Of Structural Damage In Moderately To Severely Active Rheumatoid Arthritis (Ra), In Patients 18 Years Of Age Or Older Who Have Failed 1 Or More Disease Modifying Antirheumatic Drugs (Dmards). Kineret Can Be Used Alone Or In Combination With Dmards Other Than Tumor Necrosis Factor (Tnf) Blocking Agents [See Warnings And Precautions ( 5.2 ) ]. 1.2 Cryopyrin-Associated Periodic Syndromes (Caps) Kineret Is Indicated For The Treatment Of Neonatal-Onset Multisystem Inflammatory Disease (Nomid).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Anakinra

Comments